Identification and infection control of carbapenem-resistant Enterobacterales in intensive care units
Acute and Critical Care. 2021;36(3):175-184 
Development of a risk prediction model of carbapenem-resistant Enterobacteriaceae colonization among patients in intensive care units
American Journal of Infection Control. 2018;46(11):1240-1244
Validation of a carbapenem-resistant Enterobacteriaceae colonization risk prediction model: A retrospective cohort study in Korean intensive care units
American Journal of Infection Control. 2019;47(12):1436-1442
P075: Emergence of carbapenem-resistant enterobacteriaceae in surgical and intensive care units of a hospital with low usage of carbapenem in Kano, North West Nigeria
Antimicrobial Resistance and Infection Control. 2013;2(S1):
Control of an Outbreak of Carbapenem-Resistant Acinetobacter baumannii in Medical Intensive Care Unit
American Journal of Infection Control. 2008;36(5):E103-E104
Active surveillance of carbapenem-resistant Enterobacteriaceae in intensive care units: Is it cost-effective in a nonendemic region?
American Journal of Infection Control. 2016;44(4):394-399
Carbapenem-resistant Enterobacterales colonization and subsequent infection in a neonatal intensive care unit in Shanghai, China
Infection Prevention in Practice. 2021;3(3):100147
Investigation of an Outbreak of Carbapenem-resistant Acinetobacter baumannii in the Medical Intensive Care Unit and Efficacy of Infection Control Measures
American Journal of Infection Control. 2010;38(5):e88-e89
Does Carbapenem Resistant Enterobacteriaceae Infection Drive Venous Thromboembolism in Patients Admitted to Intensive Care Units Receiving Prophylactic Anticoagulants?
. 2021;
Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units
Journal of Hospital Infection. 2002;50(2):110-114